The Patent Finder

Immunocellular Therapeutics, Ltd.

Also on record
Records under this name other than the patents Immunocellular Therapeutics, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 10 of 10 · Back to Immunocellular Therapeutics, Ltd.

PatentTitleStatus Expires Confidence
US 11,096,996Cancer vaccines and vaccination methods
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,687,607Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
Term ended
Term ended Nov 1, 2021 · High confidence
Term endedTerm ended Nov 1, 2021High confidence
US 6,376,654Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
Formerly held
Term ended
Term ended Aug 13, 2019 · From the USPTO record
Term endedTerm ended Aug 13, 2019From the USPTO record
US 7,226,750Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
Formerly held
Lapsed on the fee record
Ended Jun 5, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2019From the USPTO record
US 7,183,389Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
Lapsed on the fee record
Ended Feb 27, 2019 · High confidence
Lapsed on the fee recordEnded Feb 27, 2019High confidence
US 7,691,376Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
Formerly held
Lapsed on the fee record
Ended Apr 6, 2018 · From the USPTO record
Lapsed on the fee recordEnded Apr 6, 2018From the USPTO record
US 6,986,891Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
Formerly held
Lapsed on the fee record
Ended Jan 17, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2018From the USPTO record
US 7,498,129Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
Formerly held
Lapsed on the fee record
Ended Mar 3, 2017 · From the USPTO record
Lapsed on the fee recordEnded Mar 3, 2017From the USPTO record
US 7,435,415Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
Lapsed on the fee record
Ended Oct 14, 2016 · High confidence
Lapsed on the fee recordEnded Oct 14, 2016High confidence
US 7,435,554Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
Lapsed on the fee record
Ended Oct 14, 2016 · High confidence
Lapsed on the fee recordEnded Oct 14, 2016High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited